Why Abbott Laboratories Stock Was a Winner on Wednesday

Investors happily greeted the latest news from Abbott Laboratories (NYSE: ABT) on Hump Day. After the storied healthcare company unveiled its third-quarter results, those folks traded its stock up by 1.5%. That was good enough to edge past the S&P 500 index's 0.5% gain.For the quarter, Abbott's revenue totaled just under $10.64 billion, for year-over-year growth of almost 5%. Non-GAAP (adjusted) net income ticked up at a slightly higher rate, advancing by 6% to $2.12 billion ($1.21 per share). Both headline fundamentals beat the consensus analyst estimates, but hardly by a wide margin. Prognosticators tracking Abbott stock were modeling revenue of $10.56 billion and adjusted per-share net income of $1.20. Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool